284 related articles for article (PubMed ID: 16113452)
1. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery.
Heyder J
Proc Am Thorac Soc; 2004; 1(4):315-20. PubMed ID: 16113452
[TBL] [Abstract][Full Text] [Related]
2. Engineered aerosol medicine and drug delivery methods for optimal respiratory therapy.
Ali M
Respir Care; 2014 Oct; 59(10):1608-10. PubMed ID: 25261561
[No Abstract] [Full Text] [Related]
3. Biological variability of regional deposition of aerosol particles in the human respiratory tract.
Stahlhofen W; Gebhart J; Heyder J
Am Ind Hyg Assoc J; 1981 May; 42(5):348-52. PubMed ID: 7223643
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches to enhance pulmonary delivery of proteins and peptides.
Scheuch G; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):615-25. PubMed ID: 18204175
[TBL] [Abstract][Full Text] [Related]
5. Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations.
Zeman KL; Wu J; Bennett WD
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):363-9. PubMed ID: 20863250
[TBL] [Abstract][Full Text] [Related]
6. Deposition pattern of droplets from medical nebulizers in the human respiratory tract.
Stahlhofen W; Gebhart J; Heyder J; Scheuch G
Bull Eur Physiopathol Respir; 1983; 19(5):459-63. PubMed ID: 6640164
[TBL] [Abstract][Full Text] [Related]
7. Determining the basic characteristics of aerosols suitable for studies of deposition in the respiratory tract.
Legáth L; Naus A; Halík J
J Hyg Epidemiol Microbiol Immunol; 1988; 32(3):287-97. PubMed ID: 3198910
[TBL] [Abstract][Full Text] [Related]
8. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract.
Stahlhofen W; Gebhart J; Heyder J
Am Ind Hyg Assoc J; 1980 Jun; 41(6):385-98a. PubMed ID: 7395752
[TBL] [Abstract][Full Text] [Related]
9. Clinical perspectives on pulmonary systemic and macromolecular delivery.
Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
[TBL] [Abstract][Full Text] [Related]
10. [Deposition of particles in the respiratory system].
Huchon G; Castillon du Perron M; Chrétien J
Ann Anesthesiol Fr; 1980; 21(6):653-60. PubMed ID: 6111273
[TBL] [Abstract][Full Text] [Related]
11. Targeting delivery of aerosols to different lung regions.
Bennett WD; Brown JS; Zeman KL; Hu SC; Scheuch G; Sommerer K
J Aerosol Med; 2002; 15(2):179-88. PubMed ID: 12184868
[TBL] [Abstract][Full Text] [Related]
12. Characterization of regional and local deposition of inhaled aerosol drugs in the respiratory system by computational fluid and particle dynamics methods.
Farkas A; Balásházy I; Szocs K
J Aerosol Med; 2006; 19(3):329-43. PubMed ID: 17034308
[TBL] [Abstract][Full Text] [Related]
13. Particle deposition in human respiratory system: deposition of concentrated hygroscopic aerosols.
Varghese SK; Gangamma S
Inhal Toxicol; 2009 Jun; 21(7):619-30. PubMed ID: 19459776
[TBL] [Abstract][Full Text] [Related]
14. Deposition of inhaled particles in the lungs.
Fernández Tena A; Casan Clarà P
Arch Bronconeumol; 2012 Jul; 48(7):240-6. PubMed ID: 22464044
[TBL] [Abstract][Full Text] [Related]
15. Comparison of SPECT aerosol deposition data with a human respiratory tract model.
Fleming JS; Epps BP; Conway JH; Martonen TB
J Aerosol Med; 2006; 19(3):268-78. PubMed ID: 17034303
[TBL] [Abstract][Full Text] [Related]
16. Respiratory tract deposition of polydisperse aerosols in humans.
Diu CK; Yu CP
Am Ind Hyg Assoc J; 1983 Jan; 44(1):62-5. PubMed ID: 6829424
[TBL] [Abstract][Full Text] [Related]
17. [Deposition of particles in the respiratory tract].
Lieutier-Colas F
Allerg Immunol (Paris); 2001 Feb; 33(2):59-63. PubMed ID: 11339054
[TBL] [Abstract][Full Text] [Related]
18. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
[TBL] [Abstract][Full Text] [Related]
19. Development of human respiratory airway models: A review.
Ahookhosh K; Pourmehran O; Aminfar H; Mohammadpourfard M; Sarafraz MM; Hamishehkar H
Eur J Pharm Sci; 2020 Mar; 145():105233. PubMed ID: 31978589
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values.
Oller AR; Oberdörster G
Regul Toxicol Pharmacol; 2010; 57(2-3):181-94. PubMed ID: 20172011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
